Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Invisible Children | Main | 3D Rooms - Visual Perception Art Tricks »

February 15, 2006

Brain Industry Leaders Come Together

Email This Entry

Posted by Zack Lynch

Registrations are rolling in for the Neurotech Industry Investing and Business Conference to be held on May 18 in S.F. This is great for the networking aspect of the conference. I bet it has something to do with the March 1st early registration deadline which can save you $400. If you intend to come to the conference you shouldn't wait much longer (unless you aren't price sensitive). 118_Neurotech_Industry_Conference_Brochure-_May_18_Page_1_sm.jpgWe've put together a world-class program focused on revealing the critical trends driving the development of new drugs, devices and diagnostics for the brain and nervous system. (Agenda here)

Here is the list of confirmed speakers as of today:

Floyd E. Bloom, MD, Chairman, CSO & Founding CEO, Neurome
Mark Carney, President & CEO, Andara Life Science
Jim Cavuoto, Editor, Neurotech Reports
Mark Cochran, PhD, Managing Director, NeuroVentures Capital
Donald deBethizy, PhD, President & CEO, Targacept
Frank Eeckman, MD, PhD, Neurotech Insights, Centient
Matt Fust, Sr. VP & Chief Financial Officer, Jazz Pharmaceuticals
Steven Gerrish, Director of Business Development Purdue Research Foundation
Jennifer Griffiths, Director, Search & Evaluation, Global Business Development & Licensing, Novartis
Stephen Hoffman, MD, PhD, General Partner, Techno Venture Management
Allan Jones, PhD, Director, Allen Institute for Brain Science
Michael Kauffman, MD, PhD, President & CEO, Predix
Johnathan Kil, MD, President & CEO, Sound Pharmaceuticals
Lothar Krinke, PhD, Sr. Director, Business Development, Medtronic Neurological
Casey Lynch, Managing Partner, NeuroInsights Managing Director, Science Futures
John Lyon, CEO, Leptos Biomedical
Lore Harp McGovern, Founder, McGovern Institute for Brain Research at MIT
Martin McGlynn, President & CEO, StemCells, Inc.
William C. Mobley, MD, PhD, Director, Neuroscience Institute at Stanford
Jeffrey Ostrove, PhD, President & CEO, Ceregene
Rodney Pearlman, PhD, President & CEO, Saegis Pharmaceuticals
Roger Quy, PhD, General Partner, Technology Partners
Dr. Christine de los Reyes, Senior Director, Licensing & Development, Pfizer
Wendye Robbins, MD, Clinical Professor of Anesthesia, Stanford University, Founder, Efflux Co-founder, NeurogesX
William Sawyers, Director, Business Development, Ernst Gallo Clinic & Research Center
John Schenk, MD, PhD, NeuroImaging Research, GE Global Research Center
Jim Schoeneck, CEO, BrainCells Inc.
Christopher Scott, Executive Director, Stanford Program on Stem Cells & Society
Bruce Shook, President & CEO, Neuronetics
Dr. Kumar Srinivasan, Senior Director, Licensing, Global Business Development, Wyeth
Rick Stewart, CEO, Amarin Corporation
Bim Strausser, MD, Bridge Biomedical
Tim Surgenor, CEO, Cyberkinetics

Planned with the assistance of our knowledgeable advisory board, this market defining one-day conference is the only place for investors, executives, entrepreneurs, and researchers to come together to extend their neurotech network.

Our Advisory Board:

Sam Barondes, MD, Director, Center Neurobiology & Psychiatry, UCSF
Nola Masterson, Managing Director, Science Futures
Bob Metcalfe, PhD, Chairman, Leadership Board, McGovern Institute for Brain Research, MIT
Dan O’Connell, Director, NeuroVentures Capital
Roger Quy, PhD, General Partner, Technology Partners
Nandini Tandon, PhD, Venture Partner, MDS Capital

As someone who has their pulse on almost everything brain related, I can tell there is no better investment of your time than attending this event. Unless, of course, you want to take the money and head off to Argentina to see the U2 concert. Register at www.neuroinsights.com.

Comments (1) + TrackBacks (0) | Category: Neurotech Industry


COMMENTS

1. Kensai on April 3, 2006 10:55 AM writes...

What I would really like to see are after-conference reports and brochures for the public. Laymen should be informed about the workings of the major players in the field.

Constantine.

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Chinese Cover of The Neuro Revolution
The Neuro Revolution Lands In China
How Neuroscience Will Change the World - My Interview on Reason.tv
Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
The Neuro Revolution Published in Japan as "Neuro Wars"
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20